M&A Deal Summary |
|
---|---|
Date | 2011-11-07 |
Target | Caliper Life Sciences |
Sector | Life Science |
Buyer(s) | Revvity |
Deal Type | Add-on Acquisition |
Deal Value | 600M USD |
Advisor(s) | Perella Weinberg Partners (Financial) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1937 |
Sector | Medical Products |
Employees | 11,000 |
Revenue | 2.8B USD (2023) |
Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity was formerly known as PerkinElmer. The Company was formed in 1937 and is based in Waltham, Massachusetts.
DEAL STATS | # |
---|---|
Overall | 22 of 36 |
Sector (Life Science) | 4 of 8 |
Type (Add-on Acquisition) | 20 of 34 |
State (Massachusetts) | 6 of 8 |
Country (United States) | 16 of 19 |
Year (2011) | 6 of 6 |
Size (of disclosed) | 3 of 10 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2011-05-16 |
Labtronics
Guelph, Ontario, Canada Labtronics Inc., an Ontario, Canada-based engages in providing procedures-based Electronic Laboratory Notebook (ELN) solutions for laboratories performing routine analysis in multiple industries. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2012-11-12 |
Shanghai Haoyuan Biotech
Shanghai, China Shanghai Haoyuan Biotech Co., Ltd. is an infectious disease diagnostics company. Shanghai Haoyuan Biotech supplies molecular infectious disease screening technologies for blood bank and clinical laboratory settings. |
Buy | - |